VANDELLI, Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.713
EU - Europa 23.425
AS - Asia 18.823
SA - Sud America 2.574
Continente sconosciuto - Info sul continente non disponibili 544
AF - Africa 496
OC - Oceania 71
Totale 92.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.606
GB - Regno Unito 6.175
IT - Italia 5.678
SE - Svezia 5.397
CN - Cina 5.217
SG - Singapore 5.210
HK - Hong Kong 2.304
BR - Brasile 1.905
VN - Vietnam 1.861
DE - Germania 1.229
RU - Federazione Russa 835
FI - Finlandia 829
BD - Bangladesh 820
TR - Turchia 816
UA - Ucraina 794
FR - Francia 727
KR - Corea 622
CA - Canada 526
IN - India 486
BG - Bulgaria 308
NL - Olanda 271
AR - Argentina 211
JP - Giappone 199
ID - Indonesia 193
MX - Messico 177
IQ - Iraq 169
ZA - Sudafrica 153
IE - Irlanda 150
ES - Italia 142
PK - Pakistan 125
PL - Polonia 125
RO - Romania 124
EC - Ecuador 119
BE - Belgio 112
AE - Emirati Arabi Uniti 105
CO - Colombia 105
IL - Israele 86
MY - Malesia 78
CH - Svizzera 76
LT - Lituania 74
VE - Venezuela 67
AU - Australia 62
CL - Cile 60
CR - Costa Rica 60
IR - Iran 58
PH - Filippine 58
CZ - Repubblica Ceca 56
MA - Marocco 56
AT - Austria 55
EG - Egitto 51
UZ - Uzbekistan 51
JM - Giamaica 50
SA - Arabia Saudita 48
TN - Tunisia 44
HN - Honduras 42
SC - Seychelles 41
TT - Trinidad e Tobago 41
LU - Lussemburgo 38
PR - Porto Rico 38
DZ - Algeria 37
PY - Paraguay 37
PE - Perù 36
TH - Thailandia 36
PT - Portogallo 35
JO - Giordania 33
NP - Nepal 33
TW - Taiwan 33
GT - Guatemala 32
NI - Nicaragua 31
KE - Kenya 30
GR - Grecia 29
SV - El Salvador 25
EU - Europa 23
GP - Guadalupe 22
AZ - Azerbaigian 21
KZ - Kazakistan 21
CW - ???statistics.table.value.countryCode.CW??? 20
DO - Repubblica Dominicana 19
DK - Danimarca 18
ET - Etiopia 18
UY - Uruguay 18
EE - Estonia 17
MD - Moldavia 17
AL - Albania 16
HU - Ungheria 16
BO - Bolivia 15
LB - Libano 15
OM - Oman 14
RS - Serbia 14
SN - Senegal 14
BY - Bielorussia 12
KG - Kirghizistan 12
NO - Norvegia 11
PA - Panama 10
SI - Slovenia 10
AM - Armenia 9
CY - Cipro 9
NZ - Nuova Zelanda 9
BH - Bahrain 8
HR - Croazia 8
Totale 91.958
Salva come PNG Salva come JPEG
Città #
Ashburn 6.179
Southend 4.606
Santa Clara 3.653
Stockholm 3.594
Singapore 3.230
Fairfield 2.823
Hong Kong 2.257
Chandler 2.168
Woodbridge 2.028
San Jose 2.013
Hefei 1.715
Chicago 1.627
Jacksonville 1.542
Council Bluffs 1.469
Houston 1.434
Seattle 1.211
Wilmington 1.181
Dearborn 1.132
Ann Arbor 1.074
Nyköping 1.028
Los Angeles 1.019
Beijing 984
Cambridge 979
London 788
Modena 655
Ho Chi Minh City 620
Seoul 530
Helsinki 521
New York 493
Milan 490
The Dalles 486
Izmir 461
Hanoi 429
Salt Lake City 398
Dallas 349
Princeton 328
Sofia 291
Rome 289
Buffalo 284
San Diego 273
Eugene 265
Lauterbourg 254
São Paulo 241
Bologna 225
Moscow 202
Des Moines 196
Shanghai 194
Redwood City 185
Tampa 171
Phoenix 167
Elk Grove Village 166
Munich 160
Columbus 153
Orem 145
Tokyo 141
Frankfurt am Main 130
Bremen 124
Toronto 123
Boardman 120
Dublin 117
Jakarta 117
Fremont 114
Naples 102
Atlanta 99
Reggio Emilia 96
Brussels 94
Washington 94
Lancaster 92
Miami 92
Chennai 91
Brooklyn 87
Guangzhou 87
Montreal 85
Falls Church 83
Denver 78
Johannesburg 76
Sterling 75
Warsaw 72
Da Nang 71
Turin 71
Haiphong 69
North Bergen 68
Parma 68
Florence 61
Amsterdam 60
Baghdad 58
Catania 57
Detroit 55
Bari 54
Dulles 54
Mexico City 54
Como 53
Nanjing 53
Norwalk 51
Charlotte 49
Mumbai 49
Turku 49
Kent 47
Pittsburgh 47
San Francisco 46
Totale 62.988
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.378
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.069
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 626
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 557
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 542
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 520
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 508
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 500
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 486
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 486
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 480
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 480
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 462
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 452
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 451
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 447
Cationic liposomes for gene transfection 443
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 443
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 442
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 441
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 438
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 438
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 438
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 437
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 437
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 437
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 437
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 429
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 428
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 424
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 421
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 420
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 415
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 414
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 414
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 414
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 404
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 400
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 398
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 396
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 395
Nanoparticle transport across the blood brain barrier 389
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 388
Bead coating process via an excess of crosslinking agent 387
Polymeric nanoparticles for the drug delivery to the central nervous system 387
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 387
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 387
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 383
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 382
Distribution of drugs in polymers loaded by swelling 379
Brain targeting with polymeric nanoparticles: which administration route should we take? 378
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 377
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 375
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 374
Protein corona and nanoparticles: How can we investigate on? 372
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 371
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 369
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 366
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 364
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 364
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 363
Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques 361
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 361
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 359
Microwave-treated gelatin microspheres as drug delivery system 358
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 358
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 357
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 357
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 356
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 356
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 356
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 353
A hydroxypropylcellulose (HPC) system for the immediate and controlled release of diclofenac sodium 353
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 351
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 350
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 350
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 350
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 350
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 349
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 349
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 348
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 348
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 346
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 346
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 344
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 343
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 342
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 342
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 342
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 340
A DELIVERY SYSTEM FOR THE CONCURRENT ADMINISTRATION OF HYDROCHLOROTHIAZIDE AND CAPTOPRIL 338
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 337
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 337
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 337
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 334
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 333
Functionalization of liposomes: microscopical methods for preformulative screening 332
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 332
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 331
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 331
Totale 43.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 335.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 335.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.651 0 0 0 0 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202630.072 1.679 978 2.015 3.195 4.773 1.796 2.811 1.304 6.281 2.413 1.455 1.372
2026/20278.473 649 1.533 2.493 3.233 565 0 0 0 0 0 0 0
Totale 92.646